Reperfusion Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients in Canada: Observations From the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE)

Canadian Journal of Cardiology

Volumn 28, Issue 1, 2012, Pages 40-47

  Czarnecki, Andrew ^a   Welsh, Robert C ^b   Yan, Raymond T ^c   DeYoung, J Paul ^d   Gallo, Richard ^e   Rose, Barry ^f   Grondin, Francois R ^g   Kornder, Jan M ^h   Wong, Graham C ⁱ   Fox, Keith A A ^j   Gore, Joel M ^k   Goodman, Shaun G ^a,c   Yan, Andrew T ^a,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c CANADIAN HEART RESEARCH CENTRE   (Canada)

^d Department of Diagnostic Imaging   (Canada)

^e MONTREAL HEART INSTITUTE   (Canada)

^f Health Sciences Centre St John's   (Canada)

^g Hotel Dieu de Levis Hospital   (Canada)

^h SURREY MEMORIAL HOSPITAL   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j UNIVERSITY OF EDINBURGH   (United Kingdom)

^k UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CANADA; CARDIOGENIC SHOCK; FEMALE; FIBRINOLYSIS; HEART FAILURE; HEART MUSCLE REPERFUSION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; SHOCK; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

CANADA; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PATIENT SATISFACTION; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84856025506     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.09.011     Document Type: Article

References (32)

1. Huynh T., Perron S., O'Loughlin J., et al. Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: Bayesian hierarchical meta-analyses of randomized controlled trials and observational studies. Circulation 2009, 119:3101-3109.
2. Ko D.T., Donovan L.R., Huynh T., et al. A survey of primary percutaneous coronary intervention for patients with ST segment elevation myocardial infarction in Canadian hospitals. Can J Cardiol 2008, 24:839-843.
3. Armstrong P.W. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: The WEST (which early ST-elevation myocardial infarction therapy) study. Eur Heart J 2006, 27:1530-1538. WEST Steering Committee.
4. Bonnefoy E., Lapostolle F., Leizorovicz A., et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction:A randomised study. Lancet 2002, 360:825-829.
5. Bonnefoy E., Steg P.G., Boutitie F., et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J 2009, 30:1598-1606.
6. Armstrong P.W., Gershlick A., Goldstein P., et al. The strategic reperfusion early after myocardial infarction (STREAM) study. Am Heart J 2010, 160. 30-35.e1.
7. Goodman S.G., Huang W., Yan A.T., et al. The expanded global registry of acute coronary events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J 2009, 158:193.e1-5-201.e1-5. e1-5.
8. Rationale and design of the GRACE (global registry of acute coronary events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 2001, 141:190-199. GRACE Investigators.
9. Steg P.G., Goldberg R.J., Gore J.M., et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the global registry of acute coronary events (GRACE). Am J Cardiol 2002, 90:358-363.
10. Gale C.P., Manda S.O., Weston C.F., Birkhead J.S., Batin P.D., Hall A.S. Evaluation of risk scores for risk stratification of acute coronary syndromes in the myocardial infarction national audit project (MINAP) database. Heart 2009, 95:221-227.
11. Granger C.B., Goldberg R.J., Dabbous O., et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003, 163:2345-2353.
12. Yan A.T., Yan R.T., Tan M., et al. Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better. Eur Heart J 2007, 28:1072-1078.
13. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003, 361:13-20.
14. Kushner F.G., Hand M., Smith S.C., et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American college of cardiology Foundation/American heart association task force on practice guidelines. J Am Coll Cardiol 2009, 54:2205-2241.
15. Kalla K., Christ G., Karnik R., et al. Implementation of guidelines improves the standard of care: the viennese registry on reperfusion strategies in ST-elevation myocardial infarction (vienna STEMI registry). Circulation 2006, 113:2398-2405.
16. Tiefenbrunn A.J., Chandra N.C., French W.J., Gore J.M., Rogers W.J. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the second national registry of myocardial infarction (NRMI-2). J Am Coll Cardiol 1998, 31:1240-1245.
17. Danchin N., Vaur L., Genes N., et al. Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": one-year results from a nationwide French survey. Circulation 1999, 99:2639-2644.
18. Danchin N., Blanchard D., Steg P.G., et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French nationwide USIC 2000 registry. Circulation 2004, 110:1909-1915.
19. Widimsky P., Budesinsky T., Vorac D., et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2. Eur Heart J 2003, 24:94-104.
20. Boersma E., Maas A.C., Deckers J.W., Simoons M.L. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996, 348:771-775.
21. Berger P.B., Holmes D.R., Stebbins A.L., et al. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial: an observational study. Circulation 1997, 96:122-127.
22. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999, 341:625-634.
23. Ross A.M., Coyne K.S., Moreyra E., et al. Extended mortality benefit of early postinfarction reperfusion. GUSTO-I angiographic investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries trial. Circulation 1998, 97:1549-1556.
24. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993, 329:673-682. The GUSTO investigators.
25. Anderson J.L., Karagounis L.A., Califf R.M. Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction. Am J Cardiol 1996, 78:1-8.
26. Borgia F., Goodman S.G., Halvorsen S., et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J 2010, 31:2156-2169.
27. Fernandez-Aviles F., Alonso J.J., Castro-Beiras A., et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet 2004, 364:1045-1053.
28. Cantor W.J., Fitchett D., Borgundvaag B., et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009, 360:2705-2718.
29. Bohmer E., Hoffmann P., Abdelnoor M., Arnesen H., Halvorsen S. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). J Am Coll Cardiol 2010, 55:102-110.
30. Danchin N., Coste P., Ferrieres J., et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the French registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation 2008, 118:268-276.
31. Tu J.V., Austin P.C., Filate W.A., et al. Outcomes of acute myocardial infarction in Canada. Can J Cardiol 2003, 19:893-901.
32. Jackevicius C.A., Alter D., Cox J., et al. Acute treatment of myocardial infarction in Canada 1999-2002. Can J Cardiol 2005, 21:145-152.